Epidarex

Epidarex Capital – Catalyzing innovation in health science and technology

Apellis Completes $47 Million Series D Financing

Louisville, Ky., Feb. 12, 2016 – Apellis Pharmaceuticals, Inc., today announced that it has completed a $47.1 million Series D preferred stock financing, co-led by new investors Cormorant Asset Management, Hillhouse Capital Group and venBio Global Strategic Fund, joining existing investors Morningside Venture Investments, AJU IB…

Harpoon Medical Reports Results Of Ten Patient Early Feasibility Trial Of Its Repair System For Off-Pump, Minimally Invasive Treatment Of Mitral Valve Regurgitation (“MR”)

Outstanding clinical results reported at 2015 Transcatheter Therapeutics Conference in San Francisco. Baltimore, MD, Oct. 15, 2015 – Harpoon Medical, Inc. a medical device company focused on minimally invasive mitral valve repair, announced that it has presented clinical results of ten patients enrolled in an…